GlassScriptPhysician profile
Jessica Kelsey
NPI 1124487574
$1,359.36
in general payments reported to CMS, 2019-2025
25 companies · $422 in 2025
The $422 reported for 2025 was more than what 78% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $389 · 2023: $159 · 2024: $167 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $201.76 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $178.10 | 2022-2025 | |
| Astellas Pharma US INC | $133.69 | 2021-2024 | Veozah |
| Baxter Healthcare | $129.82 | 2025 | Tisseel |
| Exeltis, USA INC. | $80.32 | 2021-2025 | Slynd |
| Channel Medsystems, INC. | $61.14 | 2022 | |
| Aspira Women'S Health INC | $59.34 | 2023-2024 | Ova1 |
| Organon LLC | $58.29 | 2021-2025 | Nexplanon |
| Optumhealth Care Solutions, LLC | $57.47 | 2023-2024 | Vivify Health Care Team Portal 001, Eitan Medical, Zyno Solutions |
| Biogen, INC. | $53.20 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $46.15 | 2022-2024 | Twirla |
| Therapeuticsmd, INC. | $36.14 | 2022 | |
| Hologic Sales and Service, LLC | $29.92 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Avion Pharmaceuticals | $25.49 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.75 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $23.73 | 2021 | |
| Daiichi Sankyo INC. | $23.66 | 2021 | |
| Axsome Therapeutics, INC. | $21.00 | 2025 | Auvelity |
| Novo Nordisk INC | $20.09 | 2025 | |
| Evofem Biosciences, INC. | $18.89 | 2021 | |
| Shield Therapeutics INC | $18.85 | 2025 | |
| Sumitomo Pharma America, INC. | $14.75 | 2024 | Gemtesa |
| Amag Pharmaceuticals, INC. | $14.69 | 2021 | |
| Boston Scientific Corporation | $14.52 | 2022 | |
| Pfizer INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kelsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.